医療用噴射剤の世界市場

医療用噴射剤の世界市場は2030年までに4億8,340万米ドルに達する見込み

2024年に2億8,870万米ドルと推定される医療用噴射剤の世界市場は、2030年には4億8,340万米ドルに達し、分析期間2024-2030年のCAGRは9.0%で成長すると予測されます。本レポートで分析したセグメントの1つであるHFA 134Aは、CAGR 9.6%を記録し、分析期間終了時には2億6,650万米ドルに達すると予測されます。HFA 227EAセグメントの成長率は、分析期間中CAGR 7.6%と推定されます。

米国市場は7,860万米ドルと推定、中国はCAGR13.8％で成長予測

米国の医療用噴射剤市場は、2024年に7,860万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億520万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.9%と8.2%と予測されています。欧州では、ドイツがCAGR約6.4%で成長すると予測されています。

世界の医療用噴射剤市場- 主要動向と促進要因のまとめ

医療用噴射剤はどのように救命治療の提供を可能にしているのか？

医療用噴射剤は、特に定量吸入器（MDI）による呼吸器系薬剤の投与において重要な役割を果たしており、喘息、慢性閉塞性肺疾患（COPD）、その他の肺疾患などの慢性疾患の治療に欠かせないものとなっています。これらの物質は、エアロゾル化された薬剤を肺に直接効果的に送達する原動力となり、患者は迅速な作用発現とともに正確な投与量を得ることができます。ドライパウダー吸入器とは異なり、噴射剤を使用するMDIは、呼吸作動装置を操作する吸気力が不足している可能性のある小児、高齢者、重篤な患者にとって特に有益です。MDIの世界の普及により、高純度、無毒性、安定性が要求される医療グレードの噴射剤に対する一貫した需要が維持されています。ハイドロフルオロアルカン（HFA）などの現世代の噴射剤は、オゾン層破壊物質を対象とする環境規制に従って、フロン（CFC）に取って代わりました。HFAは、その安全性、不燃性、さまざまな医薬品有効成分との適合性が広く認められています。医療用噴射剤は、正確なドラッグデリバリーを保証するだけでなく、長期保存における製剤の安定性とデバイスの性能を維持する必要があります。微粒子を均一かつ安定的に分散させる能力は、効果的な吸入療法の要です。世界の呼吸器系の健康ニーズが高まり続ける中、救命治療を提供する上で医療用噴射剤の重要な機能は、世界中のドラッグデリバリーシステムの基本要素としての役割を強化しています。

医療用噴射剤市場は、環境問題や規制の圧力によってどのように変化しているのでしょうか？

医療用噴射剤業界は、環境意識の高まりと世界の規制枠組みの強化に対応して、大きな変革期を迎えています。歴史的には、オゾン層破壊作用が認識され、モントリオール議定書などの協定により国際的な禁止措置がとられるまで、クロロフルオロカーボンをベースとした噴射剤が吸入器に広く使用されていました。これによって、オゾン層には害を与えないもの、地球温暖化係数（GWP）が比較的高いハイドロフルオロアルカンの開発と採用への道が開かれました。その結果、業界は現在、気候変動に大きく寄与することなく、同じ治療効果を提供できるHFAの低GWP代替品を模索しています。ハイドロフルオロオレフィン（HFO）のような噴射剤は、ドラッグデリバリーに必要な性能特性を維持しながらGWPを大幅に低減し、環境に優しいプロファイルを提供するため、研究が進められています。米国環境保護庁や欧州医薬品庁などの規制機関は、政策ガイダンスや環境影響評価を通じて、より環境に優しい噴射剤への移行を製薬企業に促しています。メーカーは、新しい噴射剤が厳しい安全性と有効性の基準を満たすことを確実にするため、再製剤化調査、機器適合性試験、毒性研究に投資しています。このようなシフトは技術的なものだけでなく経済的なものでもあります。課題は、環境上の目標と、患者へのアクセス、手頃な価格、治療の信頼性とのバランスをとることにあります。ヘルスケアにおいて持続可能性が重要な基準となる中、より環境に優しいソリューションへの医療用噴射剤の進化は必然であり、呼吸器ケアの将来にとって極めて重要です。

臨床応用と機器適合性は、噴射剤の選択にどのように影響するか？

医療用噴射剤の選択は、目的とする臨床用途と、薬剤製剤やデリバリーデバイスに対する噴射剤の適合性に大きく影響されます。特に、呼吸器疾患の治療に使用される吸入器は、薬物の均一な分散と正確な投与を保証するために、噴射剤の特定の物理化学的特性に依存しています。適切な噴射剤は、分解や薬物動態の変化を引き起こすことなく、医薬品有効成分を溶解または懸濁できるものでなければならないです。また、不活性で、呼吸器官に刺激を与えず、患者の安全性や規制当局の承認に影響を与える汚染物質が含まれていないことも必要です。化学的適合性に加えて、機械的な考慮も最も重要です。噴射剤は、MDI装置で使用されるアクチュエーター、計量バルブ、容器と効果的に連動し、一貫した噴霧パターンと粒度分布を確保しなければならないです。これらの特性は、肺における薬物の沈着、ひいては治療の臨床効果に直接影響します。複数の有効成分を含む併用療法の場合、製剤はさらに複雑になり、圧力下および経時的な噴射剤の挙動を注意深く校正する必要があります。新たな薬剤クラスや生物製剤もまた、噴射剤開発に影響を与える新たな製剤課題を提起しています。呼吸器治療薬もエアロゾル化ルートで送達される獣医学では、噴射剤の適合性が依然として重要です。さらに、遠隔医療や在宅医療サービスが成長するにつれて、信頼性の高い噴射剤に依存する携帯可能で使いやすい吸入デバイスの重要性が増しています。これらすべての要因が組み合わさることで、医療用噴射剤の選択は恣意的なものではなく、製剤の科学とドラッグデリバリーシステムの仕組みの両方に深く組み込まれたものとなっています。

医療用噴射剤世界市場拡大の要因は？

医療用噴射剤市場の成長は、呼吸器疾患の有病率の上昇、技術の進歩、規制の変更、環境革新の組み合わせによってもたらされます。第一に、喘息、COPD、アレルギーの世界の罹患率の増加により、効果的な送達のために噴射剤に依存する吸入療法への需要が高まっています。第二に、エアロゾル科学と定量吸入器技術の進歩により、吸入投与が可能な薬剤の範囲が拡大し、噴射剤市場が拡大しています。第三に、高齢化や都市化といった人口動態の変化が、特に大気汚染が健康状態を悪化させる中低所得国において、呼吸器系疾患の負担増に寄与しています。第四に、現在進行中の医薬品研究開発投資により、既存の医薬品が吸入可能な形態に改良されつつあり、その結果、適合性が高く効率的な噴射剤の必要性が高まっています。第5に、高GWP物質からの規制シフトが環境的に持続可能な噴射剤の技術革新を促し、グリーンケミストリーと環境に適合した材料に焦点を当てた新しい市場セグメントを生み出しています。第6に、在宅ヘルスケアの拡大と、携帯可能で使い勝手の良い治療機器への需要が、信頼性の高い噴射剤に依存する小型吸入器システムの使用を後押ししています。第七に、空気の質と予防医療に対する消費者の意識の高まりが、呼吸器疾患の早期診断と一貫した治療を促し、それが吸入器ベースの薬剤の処方量を増加させています。最後に、製薬会社と機器メーカー間の協力関係の強化により、治療効果と環境持続可能性の両方を最適化する薬剤と機器の組み合わせの共同開発が可能になっています。これらの要因が相まって、ダイナミックで進化する市場環境が形成されつつあり、その中で、見過ごされがちではあるが、世界の呼吸器健康ソリューションの重要な構成要素として、情勢キーワードが存在し続けています。

セグメント

タイプ（HFA 134A、HFA 227EA、HFA-152A）、用途（プレス式定量吸入器、呼吸作動式定量吸入器）、最終用途（医療機器企業、受託製造機関、研究機関）

調査対象企業の例

• Aeropres Corporation
• Arkema S.A.
• Avanti Polar Lipids（Croda）
• BOC Healthcare（Linde Group）
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor（Orbia Advance Corp.）
• MPI Research（Charles River）
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay S.A.
• SRF Limited
• Tazzetti S.p.A.
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Medical Propellants Market to Reach US$483.4 Million by 2030

The global market for Medical Propellants estimated at US$288.7 Million in the year 2024, is expected to reach US$483.4 Million by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. HFA 134A, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$266.5 Million by the end of the analysis period. Growth in the HFA 227EA segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$78.6 Million While China is Forecast to Grow at 13.8% CAGR

The Medical Propellants market in the U.S. is estimated at US$78.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Medical Propellants Market - Key Trends & Drivers Summarized

How Are Medical Propellants Enabling the Delivery of Life-Saving Therapies?

Medical propellants play a crucial role in the administration of respiratory drugs, particularly through metered-dose inhalers (MDIs), making them indispensable in treating chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These substances serve as the driving force behind the effective delivery of aerosolized medication directly into the lungs, allowing patients to receive precise dosages with rapid onset of action. Unlike dry powder inhalers, MDIs using propellants are especially beneficial for pediatric, elderly, and critically ill patients who may lack the inspiratory strength to operate breath-actuated devices. The widespread reliance on MDIs globally has sustained consistent demand for medical-grade propellants, which are required to be highly pure, non-toxic, and stable. The current generation of propellants, such as hydrofluoroalkanes (HFAs), replaced chlorofluorocarbons (CFCs) following environmental regulations targeting ozone-depleting substances. HFAs are widely recognized for their safety, non-flammability, and compatibility with a variety of active pharmaceutical ingredients. Medical propellants must not only ensure accurate drug delivery but also maintain formulation stability and device performance over prolonged storage. Their ability to disperse fine particles evenly and consistently is a cornerstone of effective inhalation therapy. As global respiratory health needs continue to rise, the essential function of medical propellants in delivering life-saving therapies reinforces their role as a fundamental element in drug delivery systems worldwide.

How Are Environmental Concerns and Regulatory Pressures Reshaping the Medical Propellants Market?

The medical propellants industry is undergoing significant transformation in response to growing environmental awareness and tightening global regulatory frameworks. Historically, chlorofluorocarbon-based propellants were widely used in inhalers until the realization of their ozone-depleting effects led to international bans under agreements such as the Montreal Protocol. This paved the way for the development and adoption of hydrofluoroalkanes, which do not harm the ozone layer but still carry a relatively high global warming potential (GWP). As a result, the industry is now exploring low-GWP alternatives to HFAs that can offer the same therapeutic efficacy without contributing substantially to climate change. Propellants such as hydrofluoroolefins (HFOs) are being investigated for their environmentally friendly profile, offering significantly reduced GWP while maintaining performance characteristics required for drug delivery. Regulatory bodies including the U.S. Environmental Protection Agency and the European Medicines Agency are encouraging pharmaceutical companies to transition to greener propellants through policy guidance and environmental impact assessments. Manufacturers are investing in reformulation research, device compatibility testing, and toxicity studies to ensure that new propellants meet stringent safety and efficacy standards. These shifts are not only technical but also economic, as companies must adapt their production facilities and supply chains to accommodate alternative substances. The challenge lies in balancing environmental goals with patient access, affordability, and therapeutic reliability. As sustainability becomes a key criterion in healthcare, the evolution of medical propellants toward greener solutions is both inevitable and pivotal for the future of respiratory care.

How Do Clinical Applications and Device Compatibility Influence Propellant Selection?

The selection of medical propellants is heavily influenced by the intended clinical applications and the compatibility of the propellant with drug formulations and delivery devices. Most notably, inhalers used in the treatment of respiratory diseases rely on specific physicochemical properties of propellants to ensure uniform drug dispersion and accurate dosing. A suitable propellant must be able to dissolve or suspend active pharmaceutical ingredients without causing degradation or changes in pharmacokinetics. It must also be inert, non-irritating to the respiratory tract, and free from contaminants that could impact patient safety or regulatory approval. In addition to chemical compatibility, mechanical considerations are paramount. The propellant must work effectively with the actuator, metering valve, and container used in the MDI device to ensure consistent spray pattern and particle size distribution. These characteristics directly impact the deposition of the drug in the lungs and, therefore, the clinical effectiveness of the therapy. For combination therapies involving multiple active ingredients, the formulation becomes even more complex, requiring careful calibration of propellant behavior under pressure and over time. Emerging drug classes and biologics also pose new formulation challenges that influence propellant development. In veterinary medicine, where respiratory therapies are also delivered through aerosolized routes, propellant compatibility remains critical. Furthermore, as telehealth and home care services grow, portable and user-friendly inhalation devices relying on dependable propellants are becoming increasingly important. All these factors combined ensure that the choice of a medical propellant is not arbitrary but deeply embedded in both the science of formulation and the mechanics of drug delivery systems.

What Factors Are Driving the Expansion of the Global Medical Propellants Market?

The growth in the medical propellants market is driven by a combination of rising respiratory disease prevalence, technological advancement, regulatory change, and environmental innovation. First, the increasing global incidence of asthma, COPD, and allergies is creating greater demand for inhalation therapies that rely on propellants for effective delivery. Second, advances in aerosol science and metered-dose inhaler technologies are expanding the scope of medications that can be administered via inhalation, leading to a broader market for propellants. Third, demographic changes such as aging populations and urbanization are contributing to a higher burden of respiratory illnesses, particularly in low- and middle-income countries where air pollution exacerbates health conditions. Fourth, ongoing pharmaceutical R&D investments are leading to the reformulation of existing drugs into inhalable forms, thereby increasing the need for compatible and efficient propellants. Fifth, regulatory shifts away from high-GWP substances are prompting innovation in environmentally sustainable propellants, creating new market segments focused on green chemistry and eco-compliant materials. Sixth, the expansion of home healthcare and the demand for portable, user-friendly therapeutic devices are boosting the use of compact inhaler systems that depend on reliable propellants. Seventh, heightened consumer awareness of air quality and preventive care is encouraging earlier diagnosis and consistent treatment of respiratory conditions, which in turn drives prescription volume for inhaler-based medications. Lastly, increased collaboration between pharmaceutical companies and device manufacturers is enabling the co-development of drug-device combinations that optimize both therapeutic outcomes and environmental sustainability. These combined factors are shaping a dynamic and evolving market landscape in which medical propellants remain a critical, though often overlooked, component of global respiratory health solutions.

SCOPE OF STUDY:

The report analyzes the Medical Propellants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HFA 134A, HFA 227EA, HFA-152A); Application (Press Metered Dose Inhalers Application, Breath Actuated Metered Dose Inhalers Application); End-Use (Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use, Research Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Aeropres Corporation
• Arkema S.A.
• Avanti Polar Lipids (Croda)
• BOC Healthcare (Linde Group)
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor (Orbia Advance Corp.)
• MPI Research (Charles River)
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay S.A.
• SRF Limited
• Tazzetti S.p.A.
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Medical Propellants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Environmental Regulations and Phase-Out of High-GWP HFCs Throw the Spotlight on Next-Generation Low-Impact Medical Propellants
  • Rising Global Burden of Respiratory Diseases Propels Growth in Demand for Propellant-Based Inhalation Therapies
  • Shift Toward Patient-Friendly Drug Delivery Systems Expands the Addressable Market Opportunity for Pressurized MDIs
  • Approvals of New HFA Alternatives Strengthen the Business Case for Sustainable Medical Propellant Transitions
  • Inhaler Innovation for COPD and Asthma Management Accelerates Adoption of Optimized Propellant Formulations
  • Global Push to Meet Kigali Amendment Targets Spurs Urgency in Developing Eco-Conscious Medical Propellant Pipelines
  • Demand for Dose Consistency and Stability Generates Opportunities for Reformulated Propellant-Drug Combinations
  • Manufacturing Scale-Up for New Propellants Throws the Spotlight on Supply Chain Readiness and Fill-Finish Capabilities
  • Respiratory Therapy Access in Emerging Markets Sustains Growth of HFA-Based Propellants in Cost-Sensitive Regions
  • Digital Inhalers and Smart Devices Drive Innovation in Propellant Compatibility and Integration
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Medical Propellants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for HFA 134A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for HFA 227EA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for HFA-152A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Press Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Breath Actuated Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION